908 Devices (MASS) Income from Discontinued Operations (2024 - 2025)
908 Devices' (MASS) quarterly Income from Discontinued Operations came in at 204000.0 in Q4 2025, up 387.32% year-on-year from 41861.27 in Q4 2024, and up 1375.0% on a QoQ basis from 16000.0 in Q1 2025.
908 Devices (MASS) Income from Discontinued Operations (2024 - 2025) Analysis & Trends
908 Devices (MASS) has 2 years of Income from Discontinued Operations data on file, last reported at 204000.0 in Q4 2025.
- On a quarterly basis, Income from Discontinued Operations rose 387.32% year-over-year to 204000.0 in Q4 2025; TTM through Dec 2025 was 188000.0, a 166.67% increase from a year earlier, with the FY2025 full-year figure at 188000.0, up 166.67% from the prior year.
- Income from Discontinued Operations for Q4 2025 stood at 204000.0, up from 16000.0 in the prior quarter.
- Over the last five years, Income from Discontinued Operations for MASS reached as high as 204000.0 in Q4 2025 and fell as low as 72000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | - |
| 10 | 908 Devices | 256.07 Mn | 144.33 Mn | 6.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 204,000.00 |
| Mar 31, 2025 | -16,000.00 |
| Dec 31, 2024 | -71,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -70,000.00 |